carbostyril has been researched along with Adverse Drug Event in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MG; Lee, JY; Yang, BR | 1 |
| Hanawa, T; Kawano, Y | 1 |
| Kern, WV | 1 |
| Barker, D; Burr, L; Dorahy, D; France, M; Greville, H; Middleton, P; Tong, K; Visser, S; Wainwright, C; Wark, P | 1 |
| Choi, HY; Gualberto, A; Jeong, BC; Kwon, GY; Lee, HW; Park, SH; Sa, JK; Scholz, C; Sung, HH | 1 |
| Blanca-López, N; Boteanu, C; Cueva-Oliver, B; Doña, I; Fernández-Sánchez, FJ; Gajate, P; García-Avilés, MC; García-Núñez, I; Lobera, T; Moreno, E; Rojas, P; Rosado, A | 1 |
| Baecke, C; Decoutere, L; Gyssens, IC; Messiaen, P; van der Hilst, JCH | 1 |
| Akagi, L; Barrios, R; Guillemi, S; Lepik, KJ; Lima, VD; Montaner, JSG; Toy, J; Ulloa, AC; Wang, L; Yip, B | 1 |
| Choi, H; Choi, JY; Han, SH; Jeong, SJ; Jeong, W; Jung, IY; Kim, J; Kim, JJ; Kim, JM; Ku, NS; Lee, SJ; Park, JW; Seong, H; Song, YG | 1 |
| Avihingsanon, A; Cao, H; Cheng, A; Hagins, D; Hodder, S; Jiang, S; Kido, A; Kityo, C; Kulkarni, R; Squires, K | 1 |
| Ameis, SH; Cole, L; Corbett-Dick, P; Correll, CU | 1 |
| Boursi, B; Haynes, K; Lurie, I; Mamtani, R; Yang, YX | 1 |
| Popkin, MK | 1 |
| Breder, CD; Carson, WH; Marcus, R; McQuade, R; Porsteinsson, AP; Streim, JE; Swanink, R | 1 |
| Brandwein, JM; Gupta, V; Howson-Jan, K; Leber, BF; MacAlpine, K; Minden, MD; Moore, M; Schimmer, AD; Schuh, AC; Wright, J; Yee, KW | 1 |
| Appel, DI; Markowitz, JS; Peterson, YK; Wang, Z; Zhu, HJ | 1 |
| Chung, KF; Hui, CK | 1 |
| Lampiris, HW | 1 |
| Pomeraniec, F; Primeau, M; Wallace, DM | 1 |
| Eliakim-Raz, N; Lador, A; Leibovici, L; Paul, M; Skalsky, K; Yahav, D | 1 |
| Graham-Rowe, D | 1 |
| Carson, WH; Fleischhacker, WW; Forbes, RA; Jin, N; Johnson, BR; Kane, JM; McQuade, RD; Perry, PP; Sanchez, R | 1 |
| Carr, A; Lee, FJ | 1 |
| Cohen, RB; Eckhardt, SG; Gore, L; Gustafson, D; Holden, SN; Mikule, C; Morrow, M; O'Bryant, CL; Palmer, PA; Persky, M; Pierson, AS; Zhang, S | 1 |
| Berman, RM; Carson, WH; Factor, SA; Friedman, JH; Goetz, CG; Marcus, RN; Ondo, WG; Wojcieszek, J | 1 |
| Huber, T; Kaiser, J; Kaufman, L; McPherson, V | 1 |
| Nelson, SD | 1 |
7 review(s) available for carbostyril and Adverse Drug Event
| Article | Year |
|---|---|
[Development of Hospital Formulations Based on Medical Need].
Topics: Alanine; Cellulose; Chemical Phenomena; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Mouthwashes; Nanoparticles; Pharmacy Service, Hospital; Quinolones; Radiotherapy; Sodium Dodecyl Sulfate; Solubility; Solutions; Stomatitis | 2019 |
Clinical Practice Guidelines for Diagnosis and Management of Hypersensitivity Reactions to Quinolones.
Topics: Allergens; Anti-Allergic Agents; Basophil Degranulation Test; Cross Reactions; Desensitization, Immunologic; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Practice Guidelines as Topic; Quinolones; Skin Tests | 2021 |
Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor.
Topics: Adenine; Carbamates; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Drug Combinations; Drug Interactions; Drug Resistance, Viral; Drug-Related Side Effects and Adverse Reactions; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Organophosphonates; Quinolones; Randomized Controlled Trials as Topic; Thiazoles | 2012 |
Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials.
Topics: Adult; Anti-Bacterial Agents; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Humans; Macrolides; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Failure | 2013 |
Tolerability of HIV integrase inhibitors.
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Kidney; Lipid Metabolism; Oxazines; Piperazines; Pyridones; Pyrrolidinones; Quinolones; Raltegravir Potassium | 2012 |
Clinical inquiries. Which UTI therapies are safe and effective during breastfeeding?
Topics: Adult; Breast Feeding; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Family Practice; Female; Humans; Middle Aged; Milk, Human; Postpartum Period; Pregnancy; Quinolones; Risk Assessment; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Structure toxicity relationships--how useful are they in predicting toxicities of new drugs?
Topics: Analgesics; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chromans; Drug-Related Side Effects and Adverse Reactions; Flutamide; Humans; Hypoglycemic Agents; Indoles; Molecular Structure; Oxindoles; Pharmaceutical Preparations; Quinolones; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thiophenes; Troglitazone | 2001 |
6 trial(s) available for carbostyril and Adverse Drug Event
| Article | Year |
|---|---|
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring
Topics: Aged; AMP-Activated Protein Kinase Kinases; Carcinoma; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Progression-Free Survival; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Quinolones; Urothelium | 2020 |
Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Drug-Related Side Effects and Adverse Reactions; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Integrase Inhibitors; Protease Inhibitors; Quinolones; RNA, Viral; Tenofovir | 2018 |
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Behavioral Symptoms; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nursing Homes; Piperazines; Psychotic Disorders; Quinolones; United States | 2008 |
A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Quinolones; Remission Induction | 2009 |
Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Middle Aged; Piperazines; Proportional Hazards Models; Quinolones; Schizophrenia; Secondary Prevention | 2012 |
A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors.
Topics: Adult; Aged; Alkyl and Aryl Transferases; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; HSP40 Heat-Shock Proteins; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Protein Prenylation; Quinolones | 2006 |
14 other study(ies) available for carbostyril and Adverse Drug Event
| Article | Year |
|---|---|
The risk of pulmonary adverse drug reactions of rebamipide and other drugs for acid-related diseases: An analysis of the national pharmacovigilance database in South Korea.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Alanine; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmacovigilance; Quinolones; Republic of Korea | 2022 |
[Toxicity of quinolone antibiotics - new untoward effects and reevaluation of known side effects].
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Quinolones; Risk Assessment | 2019 |
Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease.
Topics: Administration, Intravenous; Adult; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Australia; Benzodioxoles; Case-Control Studies; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Forced Expiratory Volume; Humans; Male; Mutation; Quinolones; Respiratory Function Tests; Respiratory Tract Infections; Symptom Flare Up | 2020 |
Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study.
Topics: Adult; Anti-Retroviral Agents; Databases, Factual; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Oxazines; Piperazines; Prevalence; Pyridones; Quinolones; Retrospective Studies; Risk Factors | 2017 |
Adverse drug reactions to integrase strand transfer inhibitors.
Topics: Adult; British Columbia; Cobicistat; Drug-Related Side Effects and Adverse Reactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Retrospective Studies | 2018 |
Antibiotic-Related Adverse Drug Reactions at a Tertiary Care Hospital in South Korea.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Middle Aged; Nurses; Penicillins; Pharmacists; Physicians; Quinolones; Republic of Korea; Skin Diseases; Tertiary Care Centers | 2017 |
Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Piperazines; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Quinolones; Risk Assessment; Risperidone | 2013 |
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Anxiety Disorders; Case-Control Studies; Databases, Factual; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillins; Psychotic Disorders; Quinolones; Risk; Sulfonamides; United Kingdom; Young Adult | 2015 |
Gastrointestinal disorders and "medical depression".
Topics: Anti-Bacterial Agents; Antifungal Agents; Anxiety Disorders; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Penicillins; Psychotic Disorders; Quinolones; Sulfonamides | 2015 |
Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Carboxylic Ester Hydrolases; Central Nervous System Stimulants; Cluster Analysis; Drug Evaluation, Preclinical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Humans; Hydrolysis; Inactivation, Metabolic; Male; Methylphenidate; Mice; Models, Molecular; Piperazines; Quinolones | 2010 |
Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Cholinergic Antagonists; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Indans; Pulmonary Disease, Chronic Obstructive; Quinolones; Treatment Outcome | 2011 |
Serotonin toxicity in aripiprazole augmentation.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Cyproheptadine; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2012 |
Drugs: An injection of hope.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Cladribine; Clinical Trials, Phase III as Topic; Crotonates; Dimethyl Fumarate; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Fingolimod Hydrochloride; Fumarates; Humans; Hydroxybutyrates; Inflammation; Multiple Sclerosis; Natalizumab; Nitriles; Propylene Glycols; Quinolones; Risk Assessment; Sphingosine; Toluidines; United States; United States Food and Drug Administration | 2012 |
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Severity of Illness Index; Time Factors | 2006 |